Clinical Trials Directory

Trials / Conditions / Metastatic Cancers

Metastatic Cancers

12 registered clinical trials studyying Metastatic Cancers — 5 currently recruiting.

StatusTrialSponsorPhase
Recruitinge-Motion : Promoting Emotion Regulation in Chronic Cancer
NCT07236021
Université Libre de BruxellesN/A
WithdrawnA Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With
NCT06690281
National Cancer Institute (NCI)Phase 2
RecruitingAssessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910
Gene Solutions—
RecruitingA Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
NCT06678659
Recursion Pharmaceuticals Inc.Phase 1 / Phase 2
RecruitingCombination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
NCT06085716
M.D. Anderson Cancer CenterPhase 2 / Phase 3
CompletedEXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies
NCT02701907
UNICANCERN/A
CompletedRADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanc
NCT02303990
Abramson Cancer Center at Penn MedicinePhase 1
Active Not RecruitingPhase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterati
NCT02304809
UNICANCERPhase 2
RecruitingPersonalized Oncogenomics (POG) Program of British Columbia
NCT02155621
British Columbia Cancer AgencyN/A
TerminatedVertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer
NCT02376933
University of ArizonaN/A
CompletedStudy to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma
NCT02663232
Hoffmann-La Roche—
SuspendedPhase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
NCT01723306
Roger Williams Medical CenterPhase 2